1. Wu D, Zhang XT, Li LY. The role of erlotinib in the targeted treatment of non-small cell lung cancer. Chin J Lung Cancer (Chin) 2006;9(1):100–102.
2. Pang H, Wang HL, Fu L, et al. Pharmacokinetic studies of 20(R)-Ginsenoside Rg3 in human volunteers. Acta Pharm Sini (Chin) 2001;6(3):170–173.
3. Oshika Y, Nakamura M, Tokunaga T, et al. Ribozyme approach to downregulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer (NSCLC). Eur J Cancer 2000;36:2390–2396.
4. Wang HJ, Shi YK. Molecular-targeted agents in non-small lung cancer. Oncol Progress (Chin) 2006;4(2):94–104.
5. Xue DP. Progress of Shenyi capsule in antimetastasis. Chin Surg J Integr Tradit West Med (Chin) 2001;7(4):289–290.